Table 3 Sample characteristics (descriptive values) at pre-and posttreatment, 1-, 3-, 6-, 12-month follow-up and post follow-up
Pretreatment total sample (n = 24) | Pretreatment completer sample a (n = 16) | Posttreatment (n = 16) | 1-month follow-up (n = 16) | 3-month follow-up (n = 16) | 6-month follow-up (n = 14) | 12-month follow-up (n = 13) | post follow-up (n = 13) | |
|---|---|---|---|---|---|---|---|---|
Interview-based (Clinical judgment) | ||||||||
BED diagnosis, n (%) b | 21 (87.5) | 14 (87.5) | 9 (56.3) | – | – | – | – | 6 (46.2) |
Mild | 9 (37.5) | 6 (37.5) | 9 (56.3) | 5 (38.5) | ||||
Moderate | 10 (41.7) | 7 (43.8) | 0 | 1 (7.7) | ||||
Severe | 2 (8.3) | 1 (6.3) | 0 | 0 | ||||
Extreme | 0 | 0 | 0 | 0 | ||||
LOC, n (%) c | 3 (12.5) | 2 (12.5) | 7 (43.8) | – | – | – | – | 6 (46.2) |
No LOC, n (%) d | 0 | 0 | 0 | – | – | – | – | 1 (7.7) |
Patients with at least one comorbid mental disorder (%) | 20.8 | 18.8 | 12.5 | – | – | – | – | 7.7 |
Questionnaire-based (Self-report) | ||||||||
WBQ, M (SD) | 3.29 (1.97) | 3.25 (2.05) | 1.00 (0.97) | 1.56 (1.90) | 0.94 (1.34) | 1.57 (1.99) | 1.15 (1.34) | 1.62 (1.76) |
EDE-Q global score, M (SD) | 3.57 (1.20) | 3.86 (0.91) | 2.55 (1.01) | – | – | 2.48 (1.49) | – | 1.89 (1.19) |
BMI-SDS, M (SD) | 1.29 (1.28) | 1.02 (1.20) | 0.89 (1.09) | – | – | 0.95 (1.04) | – | 0.97 (1.12) |
BDI-FS, M (SD) | 6.00 (3.86) | 6.38 (2.83) | 3.13 (2.16) | 2.94 (2.41) | 3.19 (2.69) | 2.71 (2.73) | 2.15 (2.15) | 2.15 (2.30) |
ARS-D, M (SD) | 13.61 (9.09) | 14.07 (8.64) | 10.66 (7.99) | – | – | 10.36 (8.12) | – | 8.55 (6.15) |